What Stars Drive

The first module established the mechanics: stars raise the benchmark and raise the rebate share. This lesson is about what follows from attaching that much money to a measured score, which the introductory course flagged as the clearest natural experiment in high-stakes measurement anywhere in American healthcare.

The compounding value of a star

Trace the chain. A higher rating lifts the benchmark, which raises payment. It also raises the share of the bid gap returned as rebate, which funds richer supplemental benefits. Richer benefits attract enrollment. More enrollment multiplies the value of the higher payment. And plans rated five stars can enroll members year-round rather than only in the annual window.

Each link amplifies the last, which is why the difference between 3.5 and 4 stars can be worth hundreds of millions of dollars to a large plan.

What that produces

Money at that scale reliably produces effort, and the effort takes recognizable forms:

• Member outreach campaigns to close gaps before the measurement year ends.
• Medication adherence programs, since adherence measures carry heavy weight.
• Supplemental data collection to capture care that occurred but was not recorded.
• In-home assessments that address multiple measures at once.
• Customer service investment, because operational measures count too.

Worth remembering: some of this genuinely improves care, and some of it is score management. A campaign that gets a diabetic member an overdue eye exam is real improvement. Effort spent capturing documentation of care that already happened moves the score without moving the health. Both are rational responses to the incentive, and telling them apart is exactly the analytical discipline the measurement lessons in the intro course were teaching.

The regulator’s dilemma

CMS is in a permanent race with optimization. As plans learn to hit measures, the measures stop distinguishing performance, so CMS revises cut points, reweights measures, and retires topped-out ones. Each revision changes the target, which is fair in principle and destabilizing in practice for plans that budgeted against the old rules.

That instability is not merely an operational irritation. It has become the subject of serious litigation, which is where this module ends.

Key takeaways

• Stars compound through the benchmark, the rebate share, benefit richness, and enrollment, so small rating differences carry very large sums.
• The stakes produce outreach, adherence programs, supplemental data collection, and service investment, some genuine improvement and some score management.
• CMS continually revises measures and cut points to stay ahead of optimization, which destabilizes plan planning.

Sources

• KFF, Medicare Will Spend More Than $13 Billion on the Medicare Advantage Quality Bonus Program in 2026 (opens in a new tab)